"Anything you can do, I can do bigger?": the ethics and equity of growth hormone for small normal children.

Responding to requests from adult patients for neuroenhancements: guidance of the Ethics, Law and Humanities Committee. Neurology (2009) 1.25

Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet (2000) 4.34

Growth hormone therapy for short stature: panacea or Pandora's box? J Pediatr (1990) 2.66

Adult body height and childhood socioeconomic group in the Swedish population. J Epidemiol Community Health (1987) 2.28

Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr (2005) 1.81

Height and social adjustment: are extremes a cause for concern and action? Pediatrics (2004) 1.70

hGH for short stature: ethical issues raised by expanded access. J Pediatr (2004) 1.00

Considerations related to the use of recombinant human growth hormone in children. American Academy of Pediatrics Committee on Drugs and Committee on Bioethics. Pediatrics (1997) 0.99

Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med (2004) 0.90

Psychosocial correlates of short stature and delayed puberty. Pediatr Clin North Am (1987) 0.88

Moral assessment of growth hormone therapy for children with idiopathic short stature. J Med Ethics (1997) 0.83

Growth hormone therapy for the short normal child: who needs it and who wants it? The case against growth hormone therapy. J Pediatr (2000) 0.82

The psychological burden of short stature: evidence against. Eur J Endocrinol (2004) 0.81

Growth hormone: uses and abuses. BMJ (2004) 0.80

Growth hormone use in normal, short children--a plea for reason. N Engl J Med (1999) 0.79

Effects of social class differences and social mobility on growth in height, weight and body mass index in a British cohort. Ann Hum Biol (1989) 0.79